Show simple item record

dc.contributor.authorO'Brien, Johnen
dc.contributor.authorThomas, Alanen
dc.date.accessioned2015-11-11T13:34:36Z
dc.date.available2015-11-11T13:34:36Z
dc.date.issued2015-10-24en
dc.identifier.citationThe Lancet 2015, 386(10004): 1698-1706. doi: 10.1016/S0140-6736(15)00463-8en
dc.identifier.issn0140-6736
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/252585
dc.description.abstractVascular dementia is one of the most common causes of dementia after Alzheimer's disease, causing around 15% of cases. However, unlike Alzheimer's disease, there are no licensed treatments for vascular dementia. Progress in the specialty has been difficult because of uncertainties over disease classification and diagnostic criteria, controversy over the exact nature of the relation between cerebrovascular pathology and cognitive impairment, and the paucity of identifiable tractable treatment targets. Although there is an established relation between vascular and degenerative Alzheimer's pathology, the mechanistic link between the two has not yet been identified. This Series paper critiques some of the key areas and controversies, summarises treatment trials so far, and makes suggestions for what progress is needed to advance our understanding of pathogenesis and thus maximise opportunities for the search for new and effective management approaches.
dc.description.sponsorshipThe authors are supported by the Cambridge NIHR Biomedical Research Centre and Biomedical Research Unit in Dementia based at Cambridge University Hospitals NHS Foundation Trust and the University of Cambridge; and the NIHR Biomedical Research Centre and Biomedical Research Unit in Lewy body dementia based at Newcastle-upon-Tyne Hospitals, NHS Foundation Trust, and Newcastle University. We thank our colleague Professor Raj Kalaria for leading vascular dementia research, for his great support and encouragement at all times, and for providing the figures for this paper.
dc.languageEnglishen
dc.language.isoenen
dc.publisherElsevier
dc.rightsAttribution-NonCommercial-NoDerivs 2.0 UK: England & Wales*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.0/uk/*
dc.titleVascular Dementiaen
dc.typeArticle
dc.description.versionThis is the author accepted manuscript. The final version is available from Elsevier via http://dx.doi.org/10.1016/S0140-6736(15)00463-8en
prism.endingPage1706
prism.publicationDate2015en
prism.publicationNameThe Lanceten
prism.startingPage1698
prism.volume386en
dc.rioxxterms.funderNIHR
rioxxterms.versionofrecord10.1016/S0140-6736(15)00463-8en
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2015-10-24en
dc.contributor.orcidO'Brien, John [0000-0002-0837-5080]
dc.identifier.eissn1474-547X
rioxxterms.typeJournal Article/Reviewen
rioxxterms.freetoread.startdate2016-04-24


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 2.0 UK: England & Wales
Except where otherwise noted, this item's licence is described as Attribution-NonCommercial-NoDerivs 2.0 UK: England & Wales